Understanding fragile X syndrome: Insights from animal models

Cytogenetic and Genome Research

Volumn 100, Issue 1-4, 2003, Pages 111-123

  Bakker, C E ^a   Oostra, B A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; RNA BINDING PROTEIN;

ANIMAL BEHAVIOR; CIRCADIAN RHYTHM; DENDRITIC SPINE; DEPRESSION; DROSOPHILA; FRAGILE X SYNDROME; GENE EXPRESSION; GENE FUNCTION; HUMAN; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MACROORCHIDISM; MEAN CORPUSCULAR HEMOGLOBIN; METHYLATION; NERVE CELL PLASTICITY; NEUROANATOMY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; RNA TRANSPORT; SEIZURE; SYNAPTOGENESIS; TESTIS;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DROSOPHILA; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MICE; MUTATION; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

ANIMALIA;

EID: 0344962385     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072845     Document Type: Review

References (169)

1. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J: Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nature Genet 4:147-153 (1993).
2. Adinolfi S, Bagni C, Musco G, Gibson T, Mazzarella L, Pastore A: Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. RNA 5:1248-1258 (1999).
3. Aniksztejn L, Ben-Ari Y: Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature 349:67-69 (1991).
4. Ashley C Jr, Wilkinson KD, Reines D, Warren ST: FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-568 (1993a).
5. Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, Nelson DL, Warren ST: Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genet 4:244-251 (1993b).
6. Asztely F, Gustafsson B: Ionotropic glutamate receptors: Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol 12: 1-11 (1996).
7. Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M: Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81:905-915 (1995).
8. Bächner D, Manca A, Steinbach P, Wöhrle D, Just W, Vogel W, Hameister H, Poustka A: Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum molec Genet 2:2043-2050 (1993).
9. Bakker CE, de Diego Otero Y, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen AT, Oostra BA, Willemsen R: Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 258:162-170 (2000a).
10. Bakker CE, Kooy RF, D'Hooge R, Tamanini F, Willemsen R, Nieuwenhuizen I, De Vries BBA, Reyniers E, Hoogeveen AT, Willems PJ, De Deyn PP, Oostra BA: Introduction of an FMR1 transgene in the fragile X knockout mouse. Neurosci Res Comm 26:265-277 (2000b).
11. Bakker CE, Verheij C, Willemsen R, Vanderhelm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen AT, Oostra BA, Reyniers E, Deboulle K, Dhooge R, Cras P, Van Velzen D, Nagels G, Martin JJ, Dedeyn PP, Darby JK, Willems PJ: Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 78:23-33 (1994).
12. Berry-Kravis E, Huttenlocher PR: Cyclic AMP metabolism in fragile X syndrome. Ann Neurol 31:22-26 (1992).
13. Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39 (1993).
14. Bontekoe CJ, Bakker CE, Nieuwenhuizen IM, van Der Linde H, Lans H, de Lange D, Hirst MC, Oostra BA: Instability of a (CGG) (98) repeat in the Fmr1 promoter. Hum molec Genet 10:1693-1699 (2001).
15. Bontekoe CJ, McIlwain KL, Nieuwenhuizen IM, Yuva-Paylor LA, Nellis A, Willemsen R, Fang Z, Kirkpatrick L, Bakker CE, McAninch R, Cheng NC, Merriweather M, Hoogeveen AT, Nelson D, Paylor R, Oostra BA: Knockout mouse model for Fxr2: a model for mental retardation. Hum molec Genet 11:487-498 (2002).
16. Bontekoe CJM, de Graaff E, Nieuwenhuizen IM, Willemsen R, Oostra BA: FMR1 premutation allele is stable in mice. Eur J hum Genet 5:293-298 (1997).
17. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST: Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487 (2001).
18. Brown V, Small K, Lakkis L, Feng Y, Gunter C, Wilkinson KD, Warren ST: Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J biol Chem 273:15521-15527 (1998).
19. Brown WT, Jenkins EC, Cohen IL, Fish GS, Wolf-Schein EG, Gross A, Waterhouse L, Fein D, Mason-Brothers A, Ritvo E, Rittenberg BA, Bentley W, Castells S: Fragile X and autism: A multicenter survey. Am J med Genet 23:341-352 (1986).
20. Chen L, Toth M: Fragile X mice develop sensory hyper-reactivity to auditory stimuli. Neuroscience 103: 1043-1050 (2001).
21. Chiurazzi P, Pomponi MG, Pietrobono R, Bakker CE, Neri G, Oostra BA: Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum molec Genet 8:2317-2323 (1999).
22. Chiurazzi P, Pomponi MG, Willemsen R, Oostra BA, Neri G: In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum molec Genet 7:109-113 (1998).
23. Cohen IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT: Effects of age and communication level on eye contact in fragile X males and non-fragile X autistic males. Am J med Genet 38:498-502 (1991).
24. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT: Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc natl Acad Sci, USA 94: 5401-5404 (1997).
25. Corbin F, Bouillon M, Fortin A, Morin S, Rousseau F, Khandjian EW: The fragile X mental retardation protein is associated with poly(A) (+) mRNA in actively translating polyribosomes. Hum molec Genet 6:1465-1472 (1997).
26. Crusio WE, Schwegler H: Hippocampal mossy fiber distribution co-varies with open-field habituation in the mouse. Behav Brain Res 26:153-158 (1987).
27. Dailey ME, Smith SJ: The dynamics of dendritic structure in developing hippocampal slices. J Neurosci 16:2983-2994 (1996).
28. Danysz W, Zajaczkowski W, Parsons CG: Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 6:455-474 (1995).
29. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB: Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489-499 (2001).
30. De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, Van den Bos F, de Graaff E, Oostra BA, Willems PJ: A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet 3:31-35 (1993).
31. De Diego Otero Y, Bakker CE, Raghoe P, Severijnen LWFM, Hoogeveen A, Oostra BA, Willemsen R: Immunocytochemical characterization of FMRP, FXR1P and FXR2P during embryonic development in the mouse. Gene Funct Dis 1:28-37 (2000).
32. De Vries BB, van den Ouweland AM, Mohkamsing S, Duivenvoorden HJ, Mol E, Gelsema K, van Rijn M, Halley DJ, Sandkuijl LA, Oostra BA, Tibben A, Niermeijer MF: Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Am J hum Genet 61: 660-667 (1997).
33. De Vries BB, Halley DJ, Oostra BA, Niermeijer MF: The fragile X syndrome. J med Genet 35:579-589 (1998).
34. De Vries BB, Jansen CA, Duits AA, Verheij C, Willemsen R, Van Hemel JO, Van den Ouweland, AM, Niermeijer MF, Oostra BA, Halley DJ: Variable FMR1 gene methylation leads to variable phenotype in 3 males from one fragile X family. J med Genet 33:1007-1010 (1996a).
35. De Vries BB, Wiegers AM, De Graaff E, Verkerk AJ, Van Hemel JO, Halley DJ, Fryns JP, Curfs LM, Niermeijer MF, Oostra BA: Mental status and fragile X expression in relation to FMR-1 gene mutation. Eur J hum Genet 1:72-79 (1993).
36. De Vries LB, Wiegers AM, Smits AP, Mohkamsing S, Duivenvoorden HJ, Fryns J-P, Curfs LM, Halley DJ, Oostra BA, van den Ouweland AM, Niermeijer MF: Mental status of females with an FMR1 gene full mutation. Am J hum Genet 58:1025-1032 (1996b).
37. Deelen W, Bakker C, Halley D, Oostra BA: Conservation of CGG region in FMR1 gene in mammals. Am J med Genet 51:513-516 (1994).
38. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL: The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet 4:335-340 (1993).
39. D'Hooge R, Nagels G, Franck F, Bakker CE, Reyniers E, Storm K, Kooy RF, Oostra BA, Willems PJ, Dedeyn PP: Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 76:367-376 (1997).
40. Dobkin C, Rabe A, Dumas R, El Idrissi A, Hauben-stock H, Ted Brown W: Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 100:423-429 (2000).
41. Dockendorff TC, Su HS, McBride SMJ, Yang Z, Choi CH, Siwicki KK, Sehgal A, Jongens TA: Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34:973-984 (2002).
42. Eberhart DE, Malter HE, Feng Y, Warren ST: The fragile X mental retardation protein is a ribosonucleo-protein containing both nuclear localization and nuclear export signals. Hum molec Genet 5:1083-1091 (1996).
43. Feng Y, Absher D, Eberhart DE, Brown V, Malter HE, Warren ST: FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1:109-118 (1997).
44. Feng Y, Lakkis D, Warren ST: Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J hum Genet 56:106-113 (1995a).
45. Feng Y, Zhang FP, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST: Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734 (1995b).
46. Fisch GS: Is autism associated with the fragile X syndrome? Am J med Genet 43:78-86 (1992).
47. Fisch GS: What is associated with the fragile X syndrome?. Am J med Genet 48:112-121 (1993).
48. Fridell RA, Benson RE, Hua J, Bogerd HP, Cullen BR: A nuclear role for the fragile X mental retardation protein. EMBO J 15:5408-5414 (1996).
49. Frohlich KU, Madeo F: Apoptosis in yeast: a new model for aging research. Exp Gerontol 37:27-31 (2001).
50. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick R, Jr., Warren ST, Oostra BA, Nelson DL, Caskey CT: Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058 (1991).
51. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC: Fragile X syndrome without CCG amplification has an FMR1 deletion. Nature Genet 1:341-344 (1992).
52. Godfraind JM, Reyniers E, Deboulle K, Dhooge R, Dedeyn PP, Bakker CE, Oostra BA, Kooy RF, Willems PJ: Long-term potentiation in the hippocampus of fragile X knockout mice. Am J med Genet 64:246-251 (1996).
53. Gould EL, Loesch DZ, Martin MJ, Hagerman RJ, Armstrong SM, Huggins RM: Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J med Genet 95:307-315 (2000).
54. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER: Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258:1903-1910 (1992).
55. Greenough WT, Black JE, Wallace CS: Experience and brain development. Child Dev 58:539-559 (1987).
56. Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ: Synaptic regulation of protein synthesis and the fragile X protein. Proc natl Acad Sci, USA 98:7101-7106 (2001).
57. Hagerman R: Physical and behavioral phenotype, in Hagerman RJ, Cronister A (eds): Fragile-X Syndrome: Diagnosis, Treatment and Research, pp 3-87 (The Johns Hopkins University Press, Baltimore 1996).
58. Hagerman RJ: The physical and behavioral phenotype, in Hagerman RJ, Hagerman PJ (eds): Fragile-X Syndrome: Diagnosis, Treatment and Research, pp 3-109 (The Johns Hopkins University Press, Baltimore 2002).
59. Hagerman RJ, Hills J, Scharfenaker S, Lewis H: Fragile X syndrome and selective mutism. Am J med Genet 83:313-317 (1999).
60. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, Oconnor RA, Seydel C, Mazzocco M, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Caskey CT, Taylor AK: High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J med Genet 51:298-308 (1994).
61. Hansen RS, Gartler SM, Scott CR, Chen SH, Laird CD: Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum molec Genet 1: 571-578 (1992).
62. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M: Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X-syndrome Nature Genet 3:36-43 (1993).
63. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD: Analysis of neocortex in three males with the fragile X syndrome. Am J med Genet 41:289-294 (1991).
64. Hirst M, Grewal P, Flannery A, Slatter R, Maher E, Barton D, Fryns JP, Davies K: Two new cases of FMR1 deletion associated with mental impairment. Am J hum Genet 56:67-74 (1995).
65. Hornstra IK, Nelson DL, Warren ST, Yang TP High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum molec Genet 2:1659-1665 (1993).
66. Huber KM, Gallagher SM, Warren ST, Bear MF: Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc natl Acad Sci, USA 99:7746-7750 (2002).
67. Huber KM, Kayser MS, Bear MF: Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288: 1254-1257 (2000).
68. Huber KM, Roder JC, Bear MF: Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1. J Neurophysiol 86:321-325 (2001).
69. Inoue S, Shimoda M, Nishinokubi I, Siomi M, Okamura M, Nakamura A, Kobayashi S, Ishida N, Siomi H: A role for the Drosophila fragile X-related gene in circadian output. Curr Biol 12:1331 (2002).
70. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, Kooy F, Willems PJ, Cras P, Kozlowski PB, Swain RA, Weiler IJ, Greenough WT: Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am J med Genet 98:161-167 (2001).
71. Ivanco TL, Greenough WT: Altered mossy fiber distributions in adult Fmr1 (FVB). knockout mice. Hippocampus 12:47-54 (2002).
72. Jakala P, Hanninen T, Ryynanen M, Laakso M, Partanen K, Mannermaa A, Soininen H: Fragile-X: Neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes. J Clin Invest 100:331-338 (1997).
73. Jin P, Warren ST: Understanding the molecular basis of fragile X syndrome. Hum molec Genet 9:901-908 (2000).
74. Khandjian E, Corbin F, Woerly S, Rousseau F: The fragile X mental retardation protein is associated with ribosomes. Nature Genet 12:91-93 (1996).
75. Kirkpatrick LL, McIlwain KA, Nelson DL: Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics 78: 169-177 (2001).
76. Kooy RF, Dhooge R, Reyniers E, Bakker CE, Nagels G, Deboulle K, Storm K, Clincke G, Dedeyn PP, Oostra BA, Willems PJ: Transgenic mouse model for the fragile X syndrome. Am J med Genet 64:241-245 (1996).
77. Kooy RF, Reyniers E, Verhoye M, Sijbers J, Bakker CE, Oostra BA, Willems PJ, Van Der Linden A: Neuroanatomy of the fragile X knockout mouse brain studied using in vivo high resolution magnetic resonance imaging. Eur J hum Genet 7:526-532 (1999).
78. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI: Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714 (1991).
79. Kumar TR, Wang Y, Lu N, Matzuk MM: Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nature Genet 15:201-204 (1997).
80. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U: Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum molec Genet 10:329-338 (2001).
81. Langenbeck U, Schmidtke J, Bartels I, Hansmann I, Knuppel H: Mean corpuscular hemoglobin is increased in Martin-Bell syndrome. Hum Genet 66:365-366 (1984).
82. Lavedan C, Grabczyk E, Usdin K, Nussbaum RL: Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50:229-240 (1998).
83. 21 from the fragile X gene remain stable in transgenic mice. Hum Genet 100:407-414 (1997).
84. Li J, Pelletier MR, Perez Velazquez JL, Carlen PL: Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 19: 138-151 (2002).
85. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y: The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucl Acids Res 29:2276-2283 (2001).
86. Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT: Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29:243-254 (2001).
87. Maes B, Fryns JP, Van Walleghem M, Van den Berghe H: Cognitive functioning and information processing of adult mentally retarded men with fragile-X syndrome. Am J med Genet 50:190-200 (1994).
88. Malter HE, Iber JC, Willemsen R, De Graaff E, Tarleton JC, Leisti J, Warren ST, Oostra BA: Characterization of the full fragile X syndrome mutation in fetal gametes. Nature Genet 15:165-169 (1997).
89. McConkie-Rosell A, Lachiewicz A, Spiridigliozzi GA, Tarleton J, Schoenwald S, Phelan MC, Goonewardena P, Ding X, Brown WT: Evidence that methylation of the FMR1 locus is responsible for variant phenotypic expression of the fragile X syndrome. Am J hum Genet 53:800-809 (1993).
90. McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA: Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87:1339-1349 (1996).
91. Meijer H, De Graaff E, Merckx DML, Jongbloed RJE, De Die-Smulders CEM, Engelen JJM, Fryns JP, Curfs PMG, Oostra BA: A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the Fragile X syndrome. Hum molec Genet 3:615-620 (1994).
92. Merenstein SA, Sobesky WE, Taylor AK, Riddle JE, Tran HX, Hagerman RJ: Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J med Genet 64:388-394 (1996).
93. Merlin LR, Bergold PJ, Wong RK: Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. J Neurophysiol 80:989-993 (1998).
94. Mila M, Castellvi-Bel S, Sanchez A, Barcelo A, Badenas C, Mallolas J, Estivill X: Rare variants in the promoter of the fragile X syndrome gene (FMR1). Mol Cell Probes 14:115-119 (2000).
95. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Neitzel K, Stackhouse T, Hagerman RJ: Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J med Genet 83:268-279 (1999).
96. Mineur YS, Sluyter F, de WS, Oostra BA, Crusio WE: Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12: 39-46 (2002).
97. Moore PS, Chudley AE, Winter JS: Pituitary-gonadal axis in prepubertal boys with the fragile X syndrome. Am J med Genet 39:374-375 (1991).
98. Morales J, Hiesinger PR, Schroeder AJ, Kume K, Verstreken PF, Jackson FR, Nelson DL, Hassan BA: Drosophila Fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34:961-972 (2002).
99. Morgan JI, Curran T: Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci 12: 343-349 (1991).
100. Morris R Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 11:47-60 (1984).
101. Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683 (1982).
102. Musleh W, Bi X, Tocco G, Yaghoubi S, Baudry M: Glycine-induced long-term potentiation is associated with structural and functional modifications of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. Proc natl Acad Sci, USA 94:9451-9456 (1997).
103. Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R, Oostra BA: Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41:19-23 (2000).
104. Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Dalla Bernardina B, Tassinari CA, De Sarro GB, Elia M: Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40:1092-1099 (1999).
105. Nayak A, Zastrow DJ, Lickteig R, Zahniser NR, Browning MD: Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature 394:680-683 (1998).
106. Nielsen DM, Derber WJ, McClellan DA, Crnic LS: Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 927:8-17 (2002).
107. Nielsen KB, Tommerup N, Dyggve HV, Schou C: Macroorchidism and fragile X in mentally retarded males. Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28). Hum Genet 61:113-117 (1982).
108. Nimchinsky EA, Oberlander AM, Svoboda K: Abnormal development of dendritic spines in Fmr1 knock-out mice. J Neurosci 21:5139-5146 (2001).
109. Oberlé I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL: Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102 (1991).
110. Orth JM: Proliferation of Sertoli cells in fetal and postnatal rats: a quantitative autoradiographic study. Anat Rec 203:485-492 (1982).
111. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST: Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94:185-192 (1999).
112. Peier AM, McIlwain KL, Kenneson A, Warren ST, Paylor R, Nelson DL: (Over) correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum molec Genet 9:1145-1159 (2000).
113. Pelletier MR, Hablitz JJ: Tetraethylammonium-induced synaptic plasticity in rat neocortex. Cereb Cortex 6:771-780 (1996).
114. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL: Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817-822 (1991).
115. Raymond CR, Thompson VL, Tate WP, Abraham WC: Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. J Neurosci 20:969-976 (2000).
116. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB: Neurodevelopmental effects of the FMR-1 full mutation in humans. Nature Med 1:159-167 (1995).
117. Reiss AL, Aylwarth E, Freund LS, Joshi PK, Bryan RN: Neuroanatomy of fragile X syndrome: the posterior fossa. Ann Neurol 29:26-32 (1991a).
118. Reiss AL, Freund L: Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J med Genet 43:35-46 (1992).
119. Reiss AL, Freund L, Tseng JE, Joshi PK: Neuroanatomy in fragile X females: the posterior fossa. Am J hum Genet 49:279-288 (1991b).
120. Reiss AL, Patel S, Kumar AJ, Freund L: Preliminary communication: neuronanatomical variations of the posterior fossa in men with the fragile X (Martin Bell) syndrome. Am J med Genet 31:407-414 (1988).
121. Reyniers E, Vanbockstaele DR, Deboulle K, Kooy RF, Bakker CE, Oostra BA, Willems PJ: Mean corpuscular hemoglobin is not increased in Fmr1 knock-out mice. Hum Genet 97:49-50 (1996).
122. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen C, DeLozier-Blanchet C, Croquette MF, Gilgenkranz S, Jalbert P, Voelckel MA, Oberlé I, Mandel JL: Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New Engl J Med 325:1673-1681 (1991a).
123. Rousseau F, Heitz D, Oberlé I, Mandel JL: Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J med Genet 28:830-836 (1991b).
124. Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure-Kamionowska M, Connell F, Wisniewski HM: Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol 67:289-295 (1985).
125. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, et al: Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 373:151-155 (1995).
126. Schaefer GB, Thompson JN, Bodensteiner JB, McConnell JM, Kimberling WJ, Gay CT, Dutton WD, Hutchings DC, Gray SB: Hypoplasia of the cerebellar vermis in neurogenetic syndromes. Ann Neurol 39:382-385 (1996).
127. Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, Moine H: The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. Embo J 20:4803-4813 (2001).
128. Schwegler H, Crusio WE: Correlations between radial-maze learning and structural variations of septum and hippocampus in rodents. Behav Brain Res 67:29-41 (1995).
129. Schwegler H, Crusio WE, Brust I: Hippocampal mossy fibers and radial-maze learning in the mouse: a correlation with spatial working memory but not with non-spatial reference memory. Neuroscience 34: 293-298 (1990).
130. Sharpe RM: Experimental evidence for Sertoli-germ cell and Sertoli-Leydig cell interactions, in Russel LGD, Griswold MD (eds): The Sertoli cell, pp 391-418 (Cache River Press, Clearwater 1993).
131. Shimizu M, Gellibolian R, Oostra BA, Wells RD: Cloning and characterization, and properties of plasmids containing CGG triplet repeats from the FMR-1 gene. J molec Biol 258:614-626 (1996).
132. Silva AJ, Paylor R, Wehner JM, Tonegawa S: Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257:206-211 (1992a).
133. Silva AJ, Stevens CF, Tonegawa S, Wang Y: Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 257:201-206 (1992b).
134. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G: Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39 (1994).
135. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G: The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-298 (1993).
136. Sittler A, Devys D, Weber C, Mandel J-L: Alternative splicing of exon 14 determines nuclear or cytoplasmic localization of FMR1 protein isoforms. Hum molec Genet 5:95-102 (1996).
137. Slegtenhorst-Eegdeman KE, van de Kant HJG, Post M, Ruiz A, Uilenbroek JTJ, Bakker CE, Oostra BA, Grootegoed JA, de Rooij DG, Themmen APN: Macro-orchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testis development. Endocrinology 139:156-162 (1998).
138. Smeets H, Smits A, Verheij CE, Theelen J, Willemsen R, Losekoot M, Van de Burgt I, Hoogeveen AT, Oosterwijk J, Oostra BA: Normal phenotype in two brothers with a full FMR1 mutation. Hum molec Genet 4:2103-2108 (1995).
139. Smits A, Smeets D, Hamel B, Dreesen J, Dehaan A, Van Oost B: Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J med Genet 51:497-500 (1994).
140. Snyder EM, Philpot BD, Huber KM, Dong X, Fallon JR, Bear MF: Internalization of ionotropic glutamate receptors in response to mGluR activation. Nature Neurosci 4:1079-1085 (2001).
141. Steward O, Bakker CE, Willems PJ, Oostra BA: No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile-X mental retardation syndrome. Neuroreport 9:477-481 (1998).
142. Sung YJ, Conti J, Currie JR, Brown WT, Denman RB: RNAs That interact with the Fragile X syndrome RNA binding protein FMRP. Biochem biophys Res Commun 275:973-980 (2000).
143. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST: DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum molec Genet 1:397-400 (1992).
144. Tamanini F, Meijer N, Verheij C, Willems PJ, Galjaard H, Oostra BA, Hoogeveen AT: FMRP is associated to the ribosomes via RNA. Hum molec Genet 5:809-813 (1996).
145. Tamanini F, Van Unen L, Bakker C, Sacchi N, Galjaard H, Oostra BA, Hoogeveen AT: Oligomerization properties of fragile-X mental-retardation protein (FMRP). and the fragile-X-related proteins FXR1P and FXR2P. Biochem J 343:517-523 (1999).
146. Tamanini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT: Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum molec Genet 6:1315-1322 (1997).
147. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ: Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J med Genet 91:144-152 (2000).
148. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ: Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. J Am med Assoc 271:507-514 (1994).
149. Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ: Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J med Genet 84:233-239 (1999).
150. Tsien JZ: Linking Hebb's coincidence-detection to memory formation. Curr Opin Neurobiol 10:266-273 (2000).
151. Turner G, Webb T, Wake S, Robinson H: The prevalence of the fragile X syndrome. Am J med Genet 64:196-197 (1996).
152. Van Dam D, D'Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, Oostra BA, Kooy RF, De Deyn PP: Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res 117:127-136 (2000).
153. van Heyningen V: Model organisms illuminate human genetics and disease. Mol Med 3:231-237 (1997).
154. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, Reuser AJ, Hoogeveen AT, Oostra BA: Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724 (1993).
155. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, Van Ommen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST: Identification of a gene (FMR-1). containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914 (1991).
156. Wan L, Dockendorff TC, Jongens TA, Dreyfuss G: Characterization of dFMR1, a Drosophila melanogaster homolog of the Fragile X mental retardation protein. Mol Cell Biol 20:8536-8547 (2000).
157. Weiler IJ, Greenough WT: Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. Am J med Genet 83:248-252 (1999).
158. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT: Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc natl Acad Sci, USA 94:5395-5400 (1997).
159. Wells RD: Molecular basis of genetic instability of triplet repeats. J biol Chem 271:2875-2878 (1996).
160. White EL, Weinfeld L, Lev DL: A survey of morphogenesis during the early postnatal period in PMBSF barrels of mouse SmI cortex with emphasis on barrel D4. Somatosens Mot Res 14:34-55 (1997).
161. n triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol Cell Biol 19:5675-5684 (1999).
162. Willemsen R, Bontekoe C, Tamanini F, Galjaard H, Hoogeveen AT, Oostra BA: Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem biophys Res Comm 225:27-33 (1996).
163. Wöhrle D, Kotzot D, Hirst MC, Manca A, Korn B, Schmidt A, Barbi G, Rott HD, Poustka A, Davies KE, Steinbach P: A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J hum Genet 51:299-306 (1992).
164. Wöhrle D, Salat U, Glaser D, Mucke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P: Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J med Genet 35:103-111 (1998).
165. Wohrle D, Schwemmle S, Steinbach P: DNA methylation and triplet repeat stability: New proposals addressing actual questions on the CGG repeat of
166. Wong RK, Bianchi R, Taylor GW, Merlin LR: Role of metabotropic glutamate receptors in epilepsy. Adv Neurol 79:685-698 (1999).
167. Wu ZL, Thomas SA, Villacres EC, Xia Z, Simmons ML, Chavkin C, Palmiter RD, Storm DR: Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc natl Acad Sci, USA 92:220-224 (1995).
168. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P, Lubke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B: Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284:1805-1811 (1999).
169. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, Speese SD, Rubin GM, Broadie K: Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to Control synaptic structure and function. Cell 107:591-603 (2001).